Clinical Trials
5
Active:0
Completed:3
Trial Phases
3 Phases
Phase 1:1
Phase 2:3
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (60.0%)Phase 1
1 (20.0%)Phase 4
1 (20.0%)Evaluation and Comparison of Efficacy of PeriActive Mouthwash to Chlorhexidine 0.12% Mouth Rinse
Phase 4
- Conditions
- Periodontal Diseases
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Izun Pharma Ltd
- Target Recruit Count
- 44
- Registration Number
- NCT02987634
Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV
Phase 1
Completed
- Conditions
- Atrophic Vaginitis
- Interventions
- Drug: IZN-6NVS Cream
- First Posted Date
- 2014-12-10
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Izun Pharma Ltd
- Target Recruit Count
- 50
- Registration Number
- NCT02313545
- Locations
- 🇺🇸
Eastchester Medical Associates, Bronx, New York, United States
🇺🇸Seattle Women's, Seattle, Washington, United States
🇮🇱Shaare Zedek Medical Center, Jerusalem, Israel
Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers
Phase 2
Completed
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Other: Placebo hydrogelDrug: IZN-6D4 Gel
- First Posted Date
- 2011-09-01
- Last Posted Date
- 2015-12-24
- Lead Sponsor
- Izun Pharma Ltd
- Target Recruit Count
- 82
- Registration Number
- NCT01427569
- Locations
- 🇮🇱
Wolfson Medical Center, Holon, Israel
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Izun Pharma Ltd
- Target Recruit Count
- 110
- Registration Number
- NCT01400620
- Locations
- 🇺🇸
UF Health Cancer Center, Gainesville, Florida, United States
🇺🇸University of Miami-Sylvester CCC Clinical Research Services, Miami, Florida, United States
🇺🇸Mount Sinai Beth Israel - Phillips Ambulatory Care Center, New York, New York, United States
Herbal Periodontal Patch (THPP) for Gingival Inflammation in Diabetics
Phase 2
Suspended
- Conditions
- Gingival Inflammation in Diabetic Patients
- Interventions
- Drug: Placebo PatchDrug: Transmucosal Herbal Periodontal Patch (THPP)
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2011-07-20
- Lead Sponsor
- Izun Pharma Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT00731432
- Locations
- 🇮🇱
Herzog Hospital, Jerusalem, Israel
News
No news found